Background: Ongoing neuropathic pain is a common problem in patients undergoing lumbar discectomy. Central sensitization is believed to be the main cause of maintained neuropathic pain after discectomies. Tricyclic antidepressants are known as the drug of choice for neuropathies; however their acute role is a matter of controversy. The aim of this study is to assess the acute role of amitriptyline to reduce postoperative pain and opioid consumption in single level lumbar discectomies.
Methods: Over 1 year, patients with a decision for single level lumbar laminectomy and discectomy were randomly assigned into groups A and B, each received similar capsules containing amitriptyline or matching placebo 2 hours before surgery. Same anesthetic protocol was performed. Only patients with postoperative leg pain remained in the study. Visual analog scale and morphine consumption were recorded at 6 hours intervals up to 24 hours. The results were analyzed by SPSS V. 13 and w 2 and t test were used as the statistical tests. Finally, the groups were revealed: ''A'' was amitriptyline and ''B'' was the placebo group.
Results: Pain was significantly reduced in each group at each time intervals (P<0.001). The amitriptyline group had a significantly lower pain score by the end of 24 hours (P = 0.047), whereas morphine consumption was not different statistically.
Conclusions: Preemptive amitriptyline is effective to reduce remained neuropathic pain after lumbar discectomies. The treatment of neuropathic pain should be considered before the surgery.
Key Words: amitriptyline, discectomy, laminectomy, neuropathic pain, opioid, postoperative pain (Neurosurg Q 2010;20:151-158) N europathic pain occurs when any injury, disease, or dysfunction involves the peripheral or central nervous system. A wide spectrum of mechanisms including mechanical injury, inflammation, focal ischemia, neurotoxicity, viral infections, metabolic abnormalities, and dysfunction of several neurotransmitters has been described as the causative factors. The occurrence of neuropathic pain during lumbar disc herniation (LDH), also known as sciatalgia, sciatica, painful radiculopathy, or leg pain, is a common and disabling feature for these patients. Nerve root mechanical compression and neuroinflammation are the 2 main discussed theories for its pathogenesis.
Animal studies have also shown that nerve fibers manifest exaggerated ectopic irritability at or near the injury site. This might be either owing to the abnormal distribution of sodium channels or owing to an abnormal response to endogenous pain evoked by the release of cytokines and inflammatory mediators. 1 Although this sensitization might work as a compensatory mechanism for the functional deficits of the nervous system, the result would be global sensitization of the nervous system (or central sensitization), which is responsible for the chronicity of the pain and hyperalgesia.
When no compensatory intervention exists, both central and peripheral mechanisms will be involved. Initially, the injured axon is the pain producing site. Later on, neurons of the dorsal root ganglion, and even postsynaptic neurons of the dorsal horn of the spinal cord and higher order neurons up to the cortex will be recruited to emit pain signals. 2, 3 Hence, neuropathic pain is believed to be a progressive disease of the nervous system. 1 Such processes contribute to the slow progression of the disease, which is also known as the pain memory. So, the main goal of therapeutic modalities for the neuropathic pain is to hinder the development and the progression of the pain memory with preventive methods.
The efficacy of several dugs on neuropathic pain has been tested in animal studies. These include morphine, 4 antidepressants, 5, 6 clonidine, dexamedetomidine, 7 anticonvulsants, 8 N-methyl-D-aspartic acid (NMDA) receptor antagonists, 9,10 ketoprofen, 11 magnesium sulfate, 12 and canabinoides. 13 Among these drugs, antidepressants are regarded as the mainstay of treatment and some consider them as the drug of choice for the neuropathic pain.
What makes antidepressants superior to the other drugs is their ability to inhibit the central sensitization phenomenon by their simultaneous central and peripheral effects. Animal studies have demonstrated that tricyclic antidepressants (TCADs) not only exert direct analgesic effects, but also they can facilitate morphine analgesia. 14 One fact about morphine is that despite it is widely used to control postoperative pain in LDH patients it does not relieve neuropathic pain (leg pain) as it lessens the nociceptive pain (back pain), in its typical doses.
The issue of acute potentiation of morphine analgesia by TCADs is intriguing. Only a few studies on animal models have tested this hypothesis and human studies are still rare. In this study, we tested the hypothesis that preemptive amitriptyline would reduce the postoperative neuropathic pain and would have acute effects to enhance morphine analgesia during the first 24 hours after single level lumbar laminectomy and discectomy.
MATERIALS AND METHODS
This double-blind, placebo-controlled, parallel-group randomized clinical trial recruited patients who were candidate for a standard single level lumbar laminectomy and discectomy from March 2009 to March 2010 at 2 different spine centers and was approved by the institutional review board. The aim of the study was to determine the possible efficacy of preemptive amitriptyline to reduce postdiscectomy pain and opioid consumption. During all phases of the study, the patients, the staff and surgeons, data collectors, and data analysts were all kept blinded to both study arms. The inclusion criteria were: patients in need of a single level lumbar laminectomy and discectomy, age: 18 to 60 years old, weight: 60 to 80 kg, American Society of Anesthesiologists classes I or II, and corresponding clinical and magnetic resonance imaging (MRI) findings in concordance with the patient's symptoms and signs. The exclusion criteria included: previous history of intolerance to opioids or narcotics, severe complications of morphine during the study, contraindications for amitriptyline prescription (heart block, glaucoma, etc), preoperative or intraoperative decision to use a fusion technique or to expand laminectomy to more than one level, pregnancy, inability to use patient controlled analgesia (PCA) pump, alcohol or drug addiction, history of analgesic consumption during the last 24 hours, and patient's complete relief of neuropathic pain after the operation.
The primary endpoint with respect to the efficacy of amitriptyline to decrease postoperative pain scores was a significant decrease (P<0.05) in the postoperative visual analog scale (VAS) in patients who received amitriptyline in comparison with the placebo group. The secondary endpoint was to see whether there was a significant reduction in morphine consumption (P<0.05) comparing both study arms. The proportion of patients achieving to a level of pain equal to or less than their preoperative pain scores as measured by the VAS was also considered as an additional endpoint.
To detect a decrease in VAS with a 2-sided type one error of 5% and a power of 80%, a sample size of 40 patients per group was necessary, given an anticipated dropout rate of 60%. The rational to choose this dropout rate was based on the authors' experience of patients who achieve complete leg pain relief in the immediate period after lumbar laminectomy and discectomy. To recruit this number of patients a 12-month inclusion period was anticipated.
After introducing the aims of the study to the patients and taking their informed consent to participate in the study, eligible participants were randomly allocated according to simple randomization procedures, using the numerical randomizing computer system to 1 of the 2 study arms (amitriptyline and placebo).
After the initial assessment for eligibility, 200 patients were randomly assigned to the study (100 patients in group A and 100 patients in group B). On the day of admission, a junior resident (blinded to the study) explained the aims of the study to the patients and taught them how to use the PCA pump and how to report the pain level according to the VAS. To compare the patient's pain level with the postoperative VAS and have a better understanding of the degree of postoperative pain relief, the patients were also asked to determine their maximum (during activity), average, and minimum (at rest) pain levels based on VAS.
Two hours before surgery each patient received either a capsule containing 25 mg of amitriptyline or a matching placebo capsule (similar in shape, size, color, and weight) by the head nurse (blinded to the study). They were prepacked in bottles and consecutively numbered for each patient according to the randomization schedule. Each patient was given an order number and received the capsule in the corresponding prepacked bottle. No other drug was prescribed for any patient until the induction of general anesthesia.
A similar protocol for the total intravenous anesthesia was applied. The induction was accomplished by propofol (2 mg/kg), fentanyl (1.5 mg/kg), midazolam (0.05 to 0.1 mg/kg), and atracorium (0.15 mg/kg).
Remifentanyl (1 mg/kg/min) and propofol (50 to 150 mg/ kg/min) were used to maintain anesthesia. After intubation, the patients were placed in the prone position on Wilson frame. Simple x-ray determined the appropriate level of discectomy and a 5 cm midline incision was made for all patients. After opening the fascia and subpeiosteal dissection, laminectomy and discectomy were carried out under surgical microscope. No dural tearing or nerve root injury was observed in our patients. Intraoperative monitoring included continuous electerocardiogram, pulse oximetry, blood pressure, capnogram, and Fio2; which were repeated every 10 minutes. By the end of the operation, muscle relaxants were reversed by neostigmine (40 mg/kg) and atropine (0.02 mg/kg) and the patients were transferred to the postanesthesia care unit after spontaneous ventilation and successful extubation. All patients received the bolus morphine injection (0.1 mg/kg) via the PCA pump in the postanesthesia care unit. The patients were then transferred to the intensive care unit and remain under close observation. Equal setting of the PCA pump was determined as lock out interval time: 20 minutes, bolus infusion: 0.03 mg/kg, and no maintenance infusion. Those with no leg pain (VAS = 0) on awakening were excluded from the study. Likewise, the patients were excluded if severe complication of morphine (including respiratory failure, decreased O 2 saturation to <85%, bradypnea <8/min, and severe delirium) occurred (Fig. 1) .
For the next 24 hours and at the end of each 6 hours interval, a senior resident (blinded to the study) registered morphine consumption and VAS in special datasheets. The total morphine consumption at the end of 24 hours was also registered.
Of the 200 patients enrolled in the study, 63 patients from group A and 60 patients from group B were excluded from the study after the operation (Fig. 1) . Finally, the data of 37 patients in group A and 40 patients in group B were analyzed by SPSS V.13. The t test and w 2 test were used to compare the results between the 2 groups. The demographic data (age, sex, height, weight, body mass index, occupation, and educational level) were compared between the 2 groups by t test and w 2 test. The VAS and morphine consumption at the end of each time interval (6, 12, 18 , and 24 h) and total morphine consumption were compared by t test. The percentage of patients who achieved their minimum or less than minimum preoperative VAS, and those who had complete pain relief (VAS = 0) by the end of 24 hours, were also determined and compared by t test between the 2 groups. -54 patients were excluded due to no leg pain after the surgery -5 patients were excluded due to respiratory complications -3 patients refused to continue -1patient was excluded due to Severe delirium Allocated to intervention (n=100) Received allocated intervention (n=100) Did not receive allocated intervention (n=0)
Lost to follow-up (n= 0) Discontinued intervention (n= 60)
-57 patients were excluded due to no leg pain after the surgery -2 patients were excluded due to respiratory complications -1 patient was excluded because of her inability to use PCA pump At the end of the study, the 2 groups were disclosed. Groups A and B were the amitriptyline and the placebo groups, respectively.
RESULTS
Three hundred eleven patients were initially assessed for the eligibility in our study, from which 100 patients were enrolled in each group. Sixty-three and 60 patients were also excluded postoperatively owing to different reasons from groups A and B, respectively (Fig. 1) . Finally, the data of 37 patients in the amitriptyline (A) group [17 males (45.9%) and 20 females (54.1%)] and 40 patients in the placebo (B) group [24 males (60%) and 16 females (40%)] were analyzed. The demographic data was not significantly different in the 2 study arms (Tables 1, 2 ). The operation time was 117.83 ± 10.26 minutes in group A and 113.44 ± 11.53 minutes in group B. Total fentanyl infusion was 173.26 ± 18.34 and 179.12 ± 16.63 in groups A and B, respectively. Laminectomy and discectomy were carried out on L3/L4, L4/L5, and L5/S1 intervertebral space in both the groups (Table 3) .
By the end of 24 hours, the pain decreased in each group significantly (P<0.001). Comparing the 2 groups, the amitriptyline group showed a significant reduction in pain after 24 hours (P = 0.047) ( Table 4 and Fig. 2) . Although 81% of patients in the amitriptyline group achieved their minimum or less than minimum preoperative VAS by the end of 24 hours, only 60% of the placebo group achieved this level of pain reduction. In addition, 22% of patients in the amitriptyline group and 7.5% in the placebo group achieved complete pain relief (VAS = 0) at the mentioned time; however this was not to be statistically different in our study.
The mean morphine consumption was 22 and 20 mg in the amitriptyline and placebo groups, respectively, which was not to be a statistically significant difference.
Also, the mean morphine consumption at each time interval was not statistically different between the 2 groups (Table 5) ; however in both groups morphine consumption decreased significantly over time (P<0.001).
DISCUSSION
Neuropathic pain is triggered by injury, disease, or dysfunctional status involving central or peripheral nervous system. It might be felt as a steady, intermittent, sharp or shooting, or evoked pain (hyperpathy or allodynia) by the patient.
Leg pain is a common disabling problem in patients with LDH. Although the exact mechanism producing the neuropathic pain in LDH patients is still a matter of debate, it is believed that the central and peripheral mechanisms are involved. Initially, the pain might be an axonal signal caused by the compression of herniated nucleus pulposus on the nerve root fibers. 2 Later on, other neurons at the dorsal root ganglion, posterior horn of the spinal cord, and higher order neurons up to the cortex level might treat as pain producing sites. 3 Input signals to the spinal cord from the injured nerve fibers are believed to be responsible for the chronicity of the neuropathic pain. This hypothesis is supported by studies wA: without secondary school diploma, B: secondary school diploma, C: university degree (BA, BS, or higher).
BMI indicates body mass index. on rats showing the effect of rhizotomy to block inputs from injured axons and discontinuance of behaviors associated with the neuropathic pain. 15 Human studies have also shown that local anesthetics are capable to decrease neuropathic pain. 16 TCADs are known as the drug of choice for neuropathic pain. The most known drug of all, amitriptyline, is a tricyclic with good effect on chronic headache, migraine, diabetic neuropathy, facial pain, postherpetic neuralgia, and postmastectomy pain. 17 Although numerous other drugs have also been introduced to decrease the neuropathic pain, amitriptyline is still at the top. 18 From the pharmacological standpoint, amitriptyline is effective on pain in several ways, the inhibition of noradrenalin and serotonin, antagonism to NMDA, adrenoceptors and muscarinic receptors, and substance P, 19 binding to opioid receptors and quinidine-like characteristics. 20, 21 The wide spectrum therapeutic effects and acting on different sites of pain signal transduction within the central nervous system and peripheral nervous system, makes it the drug of choice for neuropathic pain. Of note is that the analgesic effect of amitriptyline is different from its antidepressive effects. For instance, it has a wellestablished analgesic effect with a median dose of 75 mg (with apparent dose-response effect) and therapeutic range from 25 to 75 mg/d. 22 There are 2 ways to treat chronic pain with TCADs. First, they might be used when simple analgesics are not enough or have caused unusual complications. Both burning and shooting pain may respond to TCADs with this method. 23 Second, they are used in combination with usual analgesics. This method is popular for cancer pain in different regions with the simultaneous nociceptive and neuropathic features. Although the exact mechanism of analgesia is yet to be known, one of the proposed mechanisms is to affect descending pathways via the inhibition of serotonin and adrenalin uptake, which modulate pain signals within the spinal cord. Other mechanisms might be the blockage of sodium channels and NMDA receptors 24 as the gates for the pain signal transduction.
Animal studies have demonstrated that amitriptyline has direct analgesic effect and may also facilitate morphine analgesia.
14 Some other studies have also shown its role in different sites within the central nervous system and peripheral nervous system. 25 Fromm et al 26 believed amitriptyline acts on neuropathic pain through segmental inhibition of the wide-range dynamic neurons, which prevents excessive firing of these neurons. In another study, Seltzer et al 6 showed that amitriptyline was able to reduce autotomy behavior owing to its analgesic effects and not because of its sedative effects. This study suggests the peripheral effects of amitriptyline are exerted through sensory fibers or suppression of the inflammatory cells. The blockage of sodium channels is another document to support its peripheral effects. 27 Amitriptyline might also be effective on neuropathic pain via endogenous opioids. The theory has been evolved by the observations that naloxane might reverse antihyperalgesic effects of amitriptyline. 28 Other studies support the role of amitriptyline to inhibit cellular adenosine uptake. 29, 30 The importance of this finding is that adenosine has shown to be effective on nociceptive, inflammatory, and neuropathic pain. 31 Human studies have also demonstrated that intravenous adenosine diminishes neuropathic pain. 32, 33 Also, Rane et al 34 showed that adenosine induced inhibition of allodynia in sensitization models. Moreover, decreased level of adenosine in cerebrospinal fluid and plasma has been found after the inhibition of neuropathic pain. These studies support the theory that the benefits of endogenous adenosine might be decreased over time and amitrityline might delay this phenomenon through the inhibition of adenosine uptake.
Although Amitriptyline is known to be effective on chronic neuropathies, few studies have exist to show it might also be effective on acute neuropathi pain as well. 25, 35, 36 In their study on rats, Esser and Sawynok 36 demonstrated the acute effect of the drug on thermal antihyperalesia owing to alteration of adenosine level. This effect was seen when the drug was given systematically or peripherally; however it was less apparent after spinal injections. In another study on rats, a single dose of intraperitoneal amitriptyline was able to increase the threshold of mechanical allodynia 30 minutes after prescription, which lasts at least 1 hour. 25 These 2 studies support the acute effect of amitriptyline to reduce neuropathic pain. Our study also demonstrates that a single dose of preoperative oral amitriptyline causes significant reduction of neuropathic pain in lumbar discectomy patients, which is another document that shows the acute effects of amitriptyline on neuropathic pain.
In our study, morphine consumption was not statistically different between the 2 groups at each 6 hours interval and by the end of 24 hours. This is in contrary to our hypothesis that amitriptyline would decrease morphine consumption. The main reason for this might be the fact that patients have used PCA pumps to decrease their nociceptive pain (back pain) as well as neuropathic pain (leg pain). The better response of nociceptive pain to opioids than the neuropathic pain and the uncontrolled use of PCA pumps by the patients prevent us to draw any conclusion and clarify the possible role of amitripryline to reduce morphine consumption. This should be considered as a limitation in our study and probably in any other study in which nociceptive and neuropathic pain coexist.
Opioids have no long-lasting effect on neuropathic pain and their effect subsides over time. Animal studies have shown decreased level of b-endorphine within the brain and spine after traumatic injury of sciatic nerve is associated with the incidence of autotomy behaviors. 37 Also, spinal opiod receptors have decreased after dorsal rhizotomy in rats. 38 These studies are in support of decreased efficacy of opioids on neuropathic pain over time.
Remaining leg pain and numbness is not an unusual complication after lumbar discectomy. Even, genetic susceptibility to poor pain outcome after discectomy have been suggested. 39 Although the true prevalence of retained leg pain is unknown, our experience is that even with optimal surgery and satisfying postoperative MRI, leg pain and numbness may persist for weeks and months after the operation. We believe neuroinflammation has a significant role, especially during the first 24 hours; however, this needs to be assessed in a scientific manner. In a group of patients, this could be expected by intraoperative visualization of swollen and red-colored nerve roots within the foramen. In addition, surgical insult to the tissues might flare up the inflammatory process by the release of cytokines from inflammatory cells in the vicinity of the nerve root. The other explaining mechanism might be the excessive manipulation of the nerve root to find the fragmented disk material or to release the root within the foramen. This might lead to neuron excitation and hyperalgesia, which is responsible for the persistence of pain, postoperatively. In a study by Almetafy et al, 40 it was demonstrated that postdidcectomy somatosensory evoked potentials (SSEP) showed no difference during the acute phase after the operation and in 17% of cases, postoperative SSEP was worse than preoperative SSEP. Although SSEP is not a suitable outcome measure for the discectomy patients, it may show operation-induced neurophysiological changes and the possibility of postoperative exacerbation of pain.
The preoperative classification of the patient's neuropathic pain into the minimum, average, and maximum levels according to the VAS, enabled us to have a better interpretation of the pain status after the operation. VAS at a given number, for instance VAS = 4, might be felt as the minimum by one patient and as the average or maximum pain by the other. Although in our study the percentage of patients who by the end of 24 hours after the operation reached to their minimum or less than minimum preoperative pain level was different between the 2 groups (81% in the amitriptyline and 60% in the placebo group), this difference was not statistically significant. Moreover, the percentage of patients with complete postoperative pain relief by the end of 24 hours was 22% and 7.5% in the amitriptyline and placebo groups, respectively. Factors such as total discectomy and complete nerve root release, less inflammatory responses in some patients, individual and genetic varieties in pain level, lesser manipulation of nerve roots in some patients, and complete bed rest might explain this level of analgesia in our patients.
Although this study demonstrates the efficacy of preemptive amitriptyline to reduce postoperative neuropathic pain, its limitations should also be considered. One limitation in our study is that the selection of patients was only based on subjective sensation of neuropathic pain in accordance with the clinical and MRI findings. Although the necessity to perform electerophysiological studies was seldom felt in our patients, these studies help to a better clarification of the severity of axonal degeneration, demyelinization, or neuropathy. For this reason, we feel electerophysiological studies should have also been considered for the optimal matching of patients between the 2 study arms.
Confounding factors such as personality, social support, genetic variations, 41 and biopsychosocial nature of the pain also affect the threshold of pain in patients, which inevitably influence the results of our study as well. Also, the operations were performed by different senior surgeons. Although the standard laminectomy and discectomy procedures were carried out in all patients, we cannot totally exclude the surgeons' influence on the outcome.
The role of genetic factors on the postdiscectomy pain has been stressed on, recently. The expression of GTP cyclohydrolase 1 halotype (frequency: 15.4% in population) has been found to be associated with lesser postdiscectomy pain. 39 If proven in other studies, it should also be considered as an unchangeable confounding variable in pain studies.
Several factors have been suggested to predict the possible development of chronic postsurgical pain (CPSP). These include the preoperative severity of pain, acute postoperative pain, the degree of anxiety, irritable bowel syndrome, migraine, fibromyalgia, and Raynaud disease. 42 Of these, acute postoperative pain seems to be the most changeable factor, which has an important role to decrease the possibility of CPSP. [43] [44] [45] [46] Ignored postoperative pain and inadequate pain suppression not only ruins the patient-surgeon relationship, but might also increase the possibility of CPSP, which leads to the failed back surgery syndrome.
Preemptive treatment with single or multimodal therapy has been suggested to decrease postoperative pain. Although opioids are widely used to treat postoperative pain, they are more effective on spontaneous pain and show less efficiency on motion-evoked pain and their role in neuronal plasticity and reversing central sensitization process is minimal. 47 In comparison, some drugs such as TCADs, local anesthetics, cyclooxygenase-2 inhibitors, and NMDA antagonists have shown promise to control motion-evoked pain and to prevent central sensitization.
48,49

CONCLUSIONS
This study suggests that the decision to treat remained neuropathic pain after lumbar discectomies should be taken before the operation. All patients should be warned of the possibility of ongoing pain after the surgery and the need to use analgesics. This may be necessary to break the reverse cycle leading to the development of CPSP even in the best surgically treated patients. Amitriptyline is effective to decrease neuropathic pain by the end of 24 hours in discectomy patients. Further studies are suggested to compare its preemptive effect with other drugs and also to show its ongoing efficacy after the first 24 hours.
